QIM
SAGE

Quantitative Investment Management’s Sage Therapeutics SAGE Stock Holding History

Quantitative Investment Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-58,400
Closed -$4.65M – 819
2017
Q2 		$4.65M Buy
+58,400
New +$4.22M 0.07% 344

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Quantitative Investment Management's SAGE Position: Q3 2017 in Review

Quantitative Investment Management sold out of Sage Therapeutics (SAGE) in Q3 2017, closing a stake of 58,400 shares — an estimated $4.65M sold.

Quantitative Investment Management first reported a position in SAGE in Q2 2017 and held it in 1 quarter. The position peaked at $4.65M in Q2 2017. 174 funds tracked by Wall St. Rank hold SAGE as of Q3 2017.

  • Quantitative Investment Management reported no remaining Sage Therapeutics position as of Q3 2017 after selling out during the quarter.
  • Quantitative Investment Management sold 58,400 Sage Therapeutics shares in Q3 2017, an estimated $4.65M.
  • Quantitative Investment Management first reported a position in Sage Therapeutics in Q2 2017 and held it in 1 quarter.
  • Quantitative Investment Management's Sage Therapeutics position peaked at $4.65M in Q2 2017.
  • 174 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2017.

Based on Quantitative Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.